Hookworm Infections: Clinical Trials

56 trials for Hookworm Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

41 completed, 5 unknown, 3 not yet recruiting, 3 recruiting. 17 Not applicable, 13 Phase 1, 10 Phase 2, 9 Phase 3, 6 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable17Completed 13, Unknown 3, Not yet recruiting 1
Phase 113Completed 11, Recruiting 1, Terminated 1
Phase 210Completed 9, Withdrawn 1
Phase 39Completed 5, Not yet recruiting 2, Recruiting 1, Unknown 1
Phase 46Completed 4, Recruiting 1, Withdrawn 1

Follow Hookworm Infections: new trials by email Literature Review of Hookworm Infections trials Research Report on Hookworm Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
emodepside (BAY 44-4400), Mebendazole 100 MG, similar placebo to mebendazole - Trichuris Trichiura; Infection, Hookworm Infection
Phase 3Not yet recruitingSwiss Tropical & Public Health Institute3152026-11-062026-08-14
Combination Therapies for Trichuris Trichiura Infection in Schoolchildren in Honduras
Placebo, Albendazole 400 mg, Albendazole Plus Ivermectin - Trichuriasis, Strongyloidiasis
Phase 3Not yet recruitingMundo Sano Foundation3682026-11-012026-06-23
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
emodepside (BAY 44-4400), matching placebo of emodepside, Mebendazole - Trichuris Trichiura; Infection, Hookworm Infection
Phase 3CompletedSwiss Tropical & Public Health Institute3152025-11-252026-10-08
Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness
Pre-screening Phase, Screenig Phase, Randomization - Soil-Transmitted Helminths
Phase 3RecruitingInsud Pharma200002025-09-012025-09-15
Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases
Moxidectin, Ivermectin - Onchocerciasis, Ascaris Lumbricoides Infection
Phase 4RecruitingKirby Institute520002025-08-042025-11-21
Community Health Education and Hygiene Promotion Added to Deworming Among Ethnic Khmer Children in Vietnam
Albendazole 400 mg, Community Health Education and Hygiene Promotion - Soil-transmitted Helminth Infections
Not applicableCompletedCan Tho University of Medicine and Pharmacy7042025-07-012026-10-02
Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura
Oxantel Pamoate, Mebendazole - Trichuris Trichiura; Infection, Hookworm Infection
Phase 2CompletedJennifer Keiser1632025-04-162025-06-08
Immune Responses in the Skin After Hookworm Infection
Necator americanus L3 larvae - Necator Americanus Infection
Not applicableNot yet recruitingLeiden University Medical Center52024-10-012024-07-12
Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC
Ivermectin 1.5 mg ODT, Ivermectin 3 mg Oral Tablet, Albendazole 400 mg Oral Tablet - Trichuriasis, Ascariasis
Phase 2CompletedJennifer Keiser2602024-06-052025-09-22
Efficacy and Safety of Moxidectin-Albendazole Co-administration in SAC
Moxidectin 2 mg Oral Tablet, Albendazole 400 mg Oral Tablet, Placebo Moxidectin - Trichuriasis, Ascariasis
Phase 3CompletedJennifer Keiser2242024-05-142025-09-19
Evaluating Impact of Improved Floors on Health
Sealed washable floor plus behaviour change, Behaviour change intervention, Routine deworming - Diarrhoeal Disease, Hookworm Infection
Not applicableCompletedLondon School of Hygiene and Tropical Medicine22002023-04-122025-01-30
Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm
Emodepside, Albendazole 400mg - Hookworm Infections
Phase 2CompletedJennifer Keiser3202022-09-162023-06-15
Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and Hookworm
Emodepside - Trichuris Trichiura; Infection, Hookworm Infections
Phase 2CompletedJennifer Keiser4422021-08-022022-05-27
Efficacy and Safety of MOX/ALB Co-administration
Moxidectin 2 mg Oral Tablet, Albendazole 400 mg Oral Tablet, Ivermectin 3 mg Oral Tablet - Trichuriasis, Ascariasis
Phase 3CompletedJennifer Keiser2552021-06-152024-01-24
Adjunctive Ivermectin Mass Drug Administration for Malaria Control
Ivermectin, Placebo, Dihydroartemisinin-piperaquine - Malaria,Falciparum, Neglected Tropical Diseases
Phase 3UnknownLondon School of Hygiene and Tropical Medicine240002021-05-032022-02-24
Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration
moxidectin (8 mg) / albendazole (400 mg), ivermectin (200 µg/kg) / albendazole (400 mg), ALBENDAZOLE 400 Mg ORAL TABLET [ZENTEL] - Trichuriasis, Ascariasis
Phase 2 / Phase 3CompletedJennifer Keiser5362021-03-012024-12-05
Validation of INSPiRED Innovative Smart Diagnostic Devices for the Detection of Parasites Infections.
Testing, Performance
UnknownCentre de Recherche Médicale de Lambaréné4602020-03-202020-08-07
Study of the Efficacy of Oxfendazole Compared to Albendazole in the Treatment of Trichuris Trichiura Infection in Adults
oxfendazole, albendazole - Helminthiasis
Phase 2WithdrawnJohns Hopkins Bloomberg School of Public Health2019-11-012019-08-15
Efficacy and Safety of a New Chewable Versus the Swallowable Tablet of Mebendazole Against Hookworm
Mebendazole - Hookworm Infections
Phase 2CompletedSwiss Tropical & Public Health Institute3972019-07-122020-07-20
Monitoring Drug Efficacy and Anthelmintic Resistance in Soil-transmitted Helminth Programs
Benzimidazoles - Soil-transmitted Helminth Infections
CompletedUniversity Ghent94572019-05-152023-08-29

Showing 20 of 56. Sign in to see all of them.

Narrower conditions

Ancylostomiasis (41)  ·  Trichuriasis (15)  ·  Ascariasis (8)  ·  Anemia, Iron-Deficiency (6)  ·  Neglected Diseases (6)  ·  Helminthiasis (5)  ·  Hypersensitivity (4)  ·  Malaria (4)  ·  Strongyloidiasis (3)  ·  Anemia (2)  ·  Disease (2)  ·  Enterobiasis (2)  ·  Health Education (2)  ·  Intestinal Diseases, Parasitic (2)

Broader conditions

Secernentea Infections (56)  ·  Strongylida Infections (56)  ·  Infections (55)  ·  Nematode Infections (55)  ·  Parasitic Diseases (54)  ·  Helminthiasis (51)  ·  Adenophorea Infections (16)  ·  Enoplida Infections (16)  ·  Hemic and Lymphatic Diseases (9)  ·  Pathologic Processes (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Ascaridida Infections (8)  ·  Hematologic Diseases (8)  ·  Disease Attributes (7)

Interventions

Albendazole (18)  ·  Mebendazole (7)  ·  Ivermectin (6)  ·  Tablets (4)  ·  emodepside (4)  ·  moxidectin (4)  ·  Bay 44-4400 (2)  ·  Hepatitis B Vaccines (2)  ·  Therapeutics (2)  ·  oxantel pamoate (2)  ·  ASP-1 protein, Necator americanus (1)  ·  Ascorbic Acid (1)  ·  Benzimidazoles (1)  ·  Blood Specimen Collection (1)  ·  CPG-oligonucleotide (1)

Sponsors

Baylor College of Medicine (11)  ·  Jennifer Keiser (9)  ·  London School of Hygiene and Tropical Medicine (4)  ·  Swiss Tropical & Public Health Institute (4)  ·  Albert B. Sabin Vaccine Institute (3)  ·  Leiden University Medical Center (2)  ·  University Ghent (2)  ·  Albert Schweitzer Hospital (1)  ·  Bird, Christopher (1)  ·  Brugmann University Hospital (1)  ·  Can Tho University of Medicine and Pharmacy (1)  ·  Centers for Disease Control and Prevention (1)  ·  Centre de Recherche Médicale de Lambaréné (1)  ·  Insud Pharma (1)  ·  Johns Hopkins Bloomberg School of Public Health (1)

Countries

Tanzania (11)  ·  United States (8)  ·  Brazil (5)  ·  Gabon (5)  ·  Kenya (4)  ·  Côte d’Ivoire (3)  ·  Ghana (3)  ·  Laos (3)  ·  Netherlands (3)  ·  Vietnam (3)  ·  Angola (1)  ·  Australia (1)  ·  Bangladesh (1)  ·  Cambodia (1)  ·  Ethiopia (1)

Top investigators

David Diemert, MD (5)  ·  Ayola Adegnika, MD (3)  ·  David J Diemert, MD (3)  ·  Jennifer Keiser, PhD (3)  ·  Bruno Levecke, PhD (2)  ·  Jennifer Keiser, Professor (2)  ·  Ahmed K. Al-Delaimy, MSc (1)  ·  Alejandro Javier Krolewiecki, PhD, MD (1)  ·  Alejandro Krolewiecki, MD (1)  ·  Alexander Loukas, PhD (1)  ·  Anna R Last, MBChB PhD (1)  ·  Armando E Gonzalez, DVM, PhD (1)  ·  Byron Arana, MD (1)  ·  Charles Mwandawiro, PhD (1)  ·  Christian Salmon, DrSc (1)

Results publications

PMID 28464026, PMID 18396361, PMID 22633322, PMID 24550339, PMID 24603321, PMID 25733630, PMID 26170395, PMID 26482774, PMID 29673735, PMID 29780848, PMID 30388108, PMID 31006575, PMID 31077279, PMID 31193620, PMID 31369558, PMID 31369562, PMID 31398204, PMID 32405623, PMID 32645714, PMID 32668456, PMID 32926834, PMID 33150325, PMID 34597297, PMID 34632308, PMID 34665810, PMID 36354034, PMID 37195942, PMID 37195949, PMID 37196017, PMID 37357904, PMID 37419638, PMID 38394298, PMID 38513684, PMID 39153818, PMID 39551062, PMID 40480665, PMID 40675166, PMID 40975108, PMID 41861834, PMID 42486129

NIH funding

U01AI129789 (1)